T2 Biosystems Management
Management criteria checks 4/4
T2 Biosystems' CEO is John Sperzel, appointed in Jan 2020, has a tenure of 4.25 years. total yearly compensation is $865.50K, comprised of 66.4% salary and 33.6% bonuses, including company stock and options. directly owns 0.007% of the company’s shares, worth $1.19K. The average tenure of the management team and the board of directors is 5.3 years and 7.1 years respectively.
Key information
John Sperzel
Chief executive officer
US$865.5k
Total compensation
CEO salary percentage | 66.4% |
CEO tenure | 4.3yrs |
CEO ownership | 0.007% |
Management average tenure | 5.3yrs |
Board average tenure | 7.1yrs |
Recent management updates
Recent updates
Insufficient Growth At T2 Biosystems, Inc. (NASDAQ:TTOO) Hampers Share Price
Apr 18T2 Biosystems to develop, commercialize diagnostic test for early Lyme disease
Oct 13T2 Biosystems announces BARDA exercise of contract option 3 valued at $3.7M
Sep 29T2 Biosystems stock rises ~17% after hours on Baltic region distribution agreement
Sep 22T2 Biosystems' Survival Riddle
Aug 26T2 Biosystems Q2 2022 Earnings Preview
Aug 12T2 Biosystems drops 4% on Q2 guidance and 2022 outlook
Jul 06A Roadmap To T2 Biosystems Story
Mar 08T2 Biosystems (NASDAQ:TTOO) Has Debt But No Earnings; Should You Worry?
Aug 17T2 Biosystems highlights the benefits of T2MR technology vs. blood culture
Apr 27CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$866k | US$575k | -US$50m |
Sep 30 2023 | n/a | n/a | -US$50m |
Jun 30 2023 | n/a | n/a | -US$52m |
Mar 31 2023 | n/a | n/a | -US$64m |
Dec 31 2022 | US$2m | US$575k | -US$62m |
Sep 30 2022 | n/a | n/a | -US$64m |
Jun 30 2022 | n/a | n/a | -US$61m |
Mar 31 2022 | n/a | n/a | -US$55m |
Dec 31 2021 | US$4m | US$563k | -US$49m |
Sep 30 2021 | n/a | n/a | -US$47m |
Jun 30 2021 | n/a | n/a | -US$44m |
Mar 31 2021 | n/a | n/a | -US$43m |
Dec 31 2020 | US$3m | US$491k | -US$47m |
Compensation vs Market: John's total compensation ($USD865.50K) is about average for companies of similar size in the US market ($USD673.84K).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
CEO
John Sperzel (60 yo)
4.3yrs
Tenure
US$865,500
Compensation
Mr. John J. Sperzel, III, B.Sc., serves as Chief Executive Officer and Director of T2 Biosystems, Inc. since January 8, 2020 and has been its Chairman since July 23, 2021 and serves as President. Mr. Sperz...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.3yrs | US$865.50k | 0.0073% $ 1.2k | |
Chief Financial Officer | 6.3yrs | US$581.00k | 0.0026% $ 419.1 | |
Senior VP | 8.3yrs | US$622.60k | 0.0024% $ 401.1 | |
Chief People Officer | 10.1yrs | no data | no data | |
Chief Commercial Officer | 2.4yrs | no data | 0.0014% $ 229.2 | |
Senior Vice President of Science Research & Development | 2.1yrs | no data | no data |
5.3yrs
Average Tenure
59yo
Average Age
Experienced Management: TTOO's management team is seasoned and experienced (5.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.3yrs | US$865.50k | 0.0073% $ 1.2k | |
Independent Director | 3.8yrs | US$60.00k | 0.0010% $ 168.6 | |
Independent Director | 7.6yrs | US$40.00k | 0.0015% $ 252.1 | |
Lead Independent Director | 9.8yrs | US$96.00k | 0.00094% $ 153.9 | |
Independent Director | 9.8yrs | US$60.00k | 0.0014% $ 232.5 | |
Member of Clinical Advisory Board | 12.9yrs | no data | no data | |
Member of Clinical Advisory Board | 12.9yrs | no data | no data | |
Independent Director | 3.8yrs | US$50.00k | 0.0013% $ 216.1 | |
Member of Clinical Advisory Board | 12.9yrs | no data | no data | |
Member of Clinical Advisory Board | 6.7yrs | US$1.10m | no data | |
Independent Director | 2.5yrs | US$40.00k | 0.00067% $ 109.7 | |
Member of Scientific Advisory Board | 2yrs | no data | no data |
7.1yrs
Average Tenure
69yo
Average Age
Experienced Board: TTOO's board of directors are considered experienced (7.1 years average tenure).